Back to Search
DIANA BLUM, MD
MD
Neurology Physician
NPI: 1952599839Individual
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
A92277(CA)
Research & Publications (20)
Delirium following abrupt discontinuation of fluoxetine.
PMID 17913343·Clin Neurol Neurosurg·2008
5-case
Chemokine markers predict biochemical recurrence of prostate cancer following prostatectomy.
PMID 19047106·Clin Cancer Res·2008
8-other
Building community-based short-term psychosocial counseling capacity for cancer patients and their families: the Individual Cancer Assistance Network (ICAN) model.
PMID 16966310·Soc Work Health Care·2006
8-other
Dissociating perceptual and conceptual implicit memory in multiple sclerosis patients.
PMID 12372351·Brain Cogn·2002
8-other
Transfer across modality in perceptual implicit memory.
PMID 11340860·Psychon Bull Rev·2001
4-observational
ATP synthase motor components: proposal and animation of two dynamic models for stator function.
PMID 11573932·Biochem Biophys Res Commun·2001
8-other
Feruloyl esterase activity of the Clostridium thermocellum cellulosome can be attributed to previously unknown domains of XynY and XynZ.
PMID 10671457·J Bacteriol·2000
8-other
Extracellular toxicity of 6-hydroxydopamine on PC12 cells.
PMID 10754220·Neurosci Lett·2000
7-preclinical
Design and biological evaluation of novel, balanced dual PPARalpha/gamma agonists.
PMID 19326383·ChemMedChem·2009
7-preclinical
A randomized, double-blind, placebo-controlled trial of a selective COX-2 inhibitor, GW406381, in patients with postherpetic neuralgia.
PMID 19409858·J Pain·2009
4-observational
Early Tau pathology involving the septo-hippocampal pathway in a Tau transgenic model: relevance to Alzheimer's disease.
PMID 19355850·Curr Alzheimer Res·2009
7-preclinical
Aleglitazar, a new, potent, and balanced dual PPARalpha/gamma agonist for the treatment of type II diabetes.
PMID 19349176·Bioorg Med Chem Lett·2009
7-preclinical
Association of corticobasal degeneration and Huntington's disease: can Tau aggregates protect Huntingtin toxicity?
PMID 19243029·Mov Disord·2009
5-case
A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease.
PMID 19591938·Neurobiol Dis·2009
8-other
The metabolic modulators, Etomoxir and NVP-LAB121, fail to reverse pressure overload induced heart failure in vivo.
PMID 19294446·Basic Res Cardiol·2009
7-preclinical
American Society of Clinical Oncology guidance statement: the cost of cancer care.
PMID 19581533·J Clin Oncol·2009
6-review
Evaluation of GW406381 for treatment of osteoarthritis of the knee: two randomized, controlled studies.
PMID 19099009·Medscape J Med·2008
8-other
A critical evaluation of adenosine A2A receptors as potentially "druggable" targets in Huntington's disease.
PMID 18537673·Curr Pharm Des·2008
6-review
Biochemistry of Tau in Alzheimer's disease and related neurological disorders.
PMID 18466052·Expert Rev Proteomics·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 300 PASTEUR DR
STANFORD, CA 94305 - Phone
- (650) 723-4000
Quick Facts
- NPI
- 1952599839
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile